Verastem, Inc.

VSTM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $26.7M
Cost of Revenue $165.0K
Gross Profit $26.6M
Gross Margin 99.4%
Operating Expenses
Research & Development $43.6M $46.4M $19.8M $40.6M $35.4M $25.9M $21.7M $9.9M
SG&A Expense $77.3M $21.4M $17.2M $17.6M $18.2M $15.5M $10.5M $3.8M
Operating Income $-94.8M $-67.8M $-37.0M $-58.2M $-53.6M $-41.4M $-32.2M $-13.7M
Operating Margin -354.8%
Interest Expense $5.8M $559.0K
Pretax Income $-72.4M
Income Tax Expense $0
Net Income $-72.4M $-67.8M $-36.4M $-57.9M $-53.4M $-41.2M $-32.0M $-13.7M
Net Margin -271.1%
EPS (Basic) $-0.56 $-0.88 $-0.50 $-0.81 $-1.04 $-0.91 $-0.85 $-5.30
EPS (Diluted) $-0.69 $-0.88 $-0.50 $-0.81 $-1.04 $-0.91 $-0.85 $-5.30
Shares Outstanding (Basic) 129.9M 76.8M 74.0M 73.9M 54.5M 50.7M 40.7M 3.1M
Shares Outstanding (Diluted) 138.6M 76.8M 74.0M 73.9M 54.5M 50.7M 40.7M 3.1M
Dividends Per Share
← Newer Page 2 of 2 Older →